Biventricular defibrillator patients have higher complication rates after revision of recalled leads

PACE - Pacing and Clinical Electrophysiology

Volumn 35, Issue 6, 2012, Pages 665-671

  Brumberg, Genevieve E ^a   Kaseer, Bahaa ^a   Shah, Hemal ^a   Saba, Samir ^a   Jain, Sandeep ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Failure rate; Fidelis ; Implantable cardioverter defibrillator; Lead failure; Predictors

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE INFECTION; DEVICE RECALL; DEVICE REMOVAL; FEMALE; FOLLOW UP; HEMATOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY;

AGED; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; ELECTRODES, IMPLANTED; EQUIPMENT FAILURE; FEMALE; HEART VENTRICLES; HUMANS; MALE; PENNSYLVANIA; POSTOPERATIVE COMPLICATIONS; PREVALENCE; PROSTHESIS IMPLANTATION; REOPERATION; RISK ASSESSMENT; SAFETY-BASED MEDICAL DEVICE WITHDRAWALS;

EID: 84861983770     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2012.03401.x     Document Type: Article

References (28)

1. Sprint Fidelis® Lead Model 6949 Performance [Internet]. Medtronic. Available from: http://www.medtronic.com/product-advisories/ physician/sprint-fidelis/6949-LEAD-PERFORMANCE (accessed March 6, 2011).
2. Krahn AD, Champagne J, Healey JS, Cameron D, Simpson CS, Thibault B, Mangat I, et al. Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: A report from the Canadian Heart Rhythm Society Device Advisory Committee. Heart Rhythm 2008; 5:639-642.
3. Faulknier BA, Traub DM, Aktas MK, Aguila A, Rosero S, Daubert JP, Hall B, et al. Time-dependent risk of Fidelis lead failure. Am J Cardiol 2010; 105:95-99.
4. Heatherly SJ, Simmons T, Fitzgerald DM, Mitchell M. Psychological effects of implantable cardioverter-defibrillator leads under advisory [Internet]. Pacing Clin Electrophysiol 2011; 34:694-699. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21410721 (accessed April 21, 2011).
5. Hauser RG, Maisel WH, Friedman PA, Kallinen LM, Mugglin AS, Kumar K, Hodge DO, et al. Longevity of Sprint Fidelis implantable cardioverter- defibrillator leads and risk factors for failure: Implications for patient management. Circulation 2011; 123:358-363.
6. Kapa S, Hyberger L, Rea RF, Hayes DL. Complication risk with pulse generator change: Implications when reacting to a device advisory or recall. Pacing Clin Electrophysiol 2007; 30:730-733. (Pubitemid 46850036)
7. Moore JW, Barrington W, Bazaz R, Jain S, Nemec J, Ngwu O, Schwartzman D, et al. Complications of replacing implantable devices in response to advisories: A single center experience. Int J Cardiol 2009; 134:42-46.
8. Gould PA, Krahn AD. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. J Am Med Assoc 2006; 295:1907-1911.
9. Parkash R, Crystal E, Bashir J, Simpson C, Birnie D, Sterns L, Exner D, et al. Complications associated with revision of Sprint Fidelis leads: Report from the Canadian Heart Rhythm Society Device Advisory Committee. Circulation 2010; 121:2384-2387.
10. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, et al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis 2007; 45:166-173. (Pubitemid 47041006)
11. Keren A, Sears SF, Nery P, Shaw J, Green MS, Lemery R, GollobMH, et al. Psychological adjustment in ICD patients living with advisory fidelis leads. J Cardiovasc Electrophysiol 2011; 22:57-63.
12. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008; 359:1009-1017.
13. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: Frequency, mechanism, and survival impact. J Am Coll Cardiol 2008; 51:1357-1365. (Pubitemid 351443082)
14. Kallinen LM, Hauser RG, Lee KW, Almquist AK, Katsiyiannis WT, Tang CY, Melby DP, et al. Failure of impedance monitoring to prevent adverse clinical events caused by fracture of a recalled high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm 2008; 5:775-779.
15. Kallinen LM, Hauser RG, Tang C, Melby DP, Almquist AK, Katsiyiannis WT, Gornick CC. Lead integrity alert algorithm decreases inappropriate shocks in patients who have Sprint Fidelis pace-sense conductor fractures. Heart Rhythm 2010; 7:1048-1055.
16. Duray GZ, Schmitt J, Cicek-Hartvig S, Hohnloser SH, Israel CW. Complications leading to surgical revision in implantable cardioverter defibrillator patients: Comparison of patients with single-chamber, dual-chamber, and biventricular devices. Europace 2009; 11:297-302.
17. Borleffs CJW, Thijssen J, de Bie MK, van Rees JB, van Welsenes GH, van Erven L, Bax JJ, et al. Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications. Pacing Clin Electrophysiol 2010; 33:1013-1019.
18. Nery PB, Fernandes R, Nair GM, Sumner GL, Ribas CS, Menon SMD, Wang X, et al. Device-related infection among patients with pacemakers and implantable defibrillators: Incidence, risk factors, and consequences. J Cardiovasc Electrophysiol 2010; 21:786-790.
19. Gould PA, Gula LJ, Yee R, Skanes AC, Klein GJ, Krahn AD. Cardiovascular implantable electrophysiological device-related infections: A review [Internet]. Curr Opin Cardiol 2011; 26:6-11. Available from: http://www.ncbi.nlm.nih.gov/ pubmed/21076288 (accessed April 21, 2012).
20. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, Rey JL, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: Results of a large prospective study. Circulation 2007; 116:1349-1355. (Pubitemid 47417560)
21. Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, Gottipaty V, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: Results from the REPLACE registry. Circulation 2010; 122:1553-1561.
22. Martin DT, Hook BG, Chaudhry GM, Silver J. Multicenter experience with extraction of the Sprint Fidelis implantable cardioverter-defibrillator lead. J Am Coll Cardiol 2011; 57:635-636.
23. van Erven L, Morgan JM. Attitude towards redundant leads and the practice of lead extractions: A European survey. Europace 2010; 12:275-276.
24. Agarwal SK, Kamireddy S, Nemec J, Voigt A, Saba S. Predictors of complications of endovascular chronic lead extractions from pacemakers and defibrillators: A single-operator experience. J Cardiovasc Electrophysiol 2009; 20:171-175.
25. Wazni O, Epstein LM, Carrillo RG, Love C, Adler SW, Riggio DW, Karim SS, et al. Lead extraction in the contemporary setting: The LExICon study: An observational retrospective study of consecutive laser lead extractions. J Am Coll Cardiol 2010; 55:579-586.
26. Mehrotra AK, Knight BP, Smelley MP, Shah DP, Weisberg I, Baez- Escudero J, Beshai JF, et al. Medtronic Sprint Fidelis lead recall: Determining the initial 5-year management cost to Medicare. Heart Rhythm 2011; 8:1192-1197.
27. Amin MS, Ellenbogen KA. Should recent defibrillator and lead advisories affect decisions to refer patients for implantable cardioverter-defibrillator therapy? Curr Opin Cardiol 2010; 25:23-28.
28. Maisel WH. Physician management of pacemaker and implantable cardioverter defibrillator advisories. Pacing Clin Electrophysiol 2004; 27:437-442. (Pubitemid 38491390)